Cargando...
Autophagy as a mechanism of Apo2L/TRAIL resistance
Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is unique to selectively induce apoptosis in tumor cells while sparing normal cells. Thus there is tremendous interest in Apo2L/TRAIL therapy; however, drug resistance is a serious limitation. Autophagy is a cellular...
Guardado en:
| Publicado en: | Cancer Biol Ther |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6154847/ https://ncbi.nlm.nih.gov/pubmed/30067424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1472191 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|